The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSA.L Regulatory News (SSA)

  • There is currently no data for SSA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sistema PJSFC: Ad Hoc Notice

16 Aug 2022 17:55

Sistema PJSFC (SSA) Sistema PJSFC: Ad Hoc Notice 16-Aug-2022 / 19:55 MSK Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Ad Hoc Notice

Moscow, Russia – 16 August 2022 – Sistema PJSFC (“Sistema” or the “Corporation”) hereby announces that, in accordance with Federal Law No. 319-FZ on Amendments to Certain Legislative Acts of the Russian Federation (“Law No. 319”), the Corporation has submitted an application to the Ministry of Finance of the Russian Federation, seeking permission to refrain from any action to perform the automatic conversion of its global depositary receipts (“GDRs”) until the end of the period during which continuing circulation of the Corporation’s GDRs has been permitted. Earlier, in response to an application from Sistema, a Russian government commission granted permission to continue circulation of the Corporation’s GDRs outside the Russian Federation through 13 May 2023.

Background information

Law No. 319, which came into legal effect on 14 July 2022, provides for the automatic and compulsory conversion of the depositary receipts (“DRs”) of Russian companies into shares without the involvement of the depositary bank for the corresponding depositary receipts programme depending on where the rights of the DR holders are accounted for: in a Russian or a foreign depositary.

In accordance with Law No. 319, the compulsory conversion of DRs is possible if the rights to the DRs are accounted for by foreign organisations and the holders of such DRs are unable to convert them into shares of the Russian issuer as a result of the imposition of certain foreign sanctions and restrictions. In this case, such DR holders may within 90 days following 14 July 2022 submit an application for compulsory conversion of their relevant DRs to the depositary where a depo account under the depositary programme was opened to account for the rights to underlying shares of the respective Russian issuer (“DR programme Custodian” and “DR programme Depo Account”), along with documents confirming the holder’s rights to such DRs and other documents pursuant to Law No. 319. After the expiry of deadline for accepting applications for compulsory conversion, the DR programme Custodian shall open depo holder accounts for eligible applicants and transfer the respective number of underlying shares of the respective Russian issuer to such accounts.

The DR programme Custodian has the right to refuse to perform the above-mentioned actions if there are reasonable doubts about the accuracy or completeness of the information specified in the application for compulsory conversion and other submitted documents. In addition, Law No. 319 stipulates that compulsory conversion shall not be carried out if the total number of underlying shares specified in all submitted applications for compulsory conversion exceeds the number of underlying shares accounted for in the DR programme Depo Account.

This notice does not constitute legal, accounting, tax or any other kind of professional advice. This notice is purely for informational purposes and is based on the Corporation’s interpretation of the impact of Law No. 319 on its GDR programme. The Corporation shall not bear any liability whatsoever if the interpretation of the applicable laws and regulations by the relevant governmental authorities or other parties differs from the interpretation specified in this notice. GDR holders should make their own decisions as to how to proceed in connection with the enacted Law No. 319 and, if necessary, should consult their investment, legal and other advisors.

***

For further information, please visit www.sistema.ru or contact:

Public Relations

Sergei Kopytov

Tel.: +7 (495) 730 17 05

kopytov@sistema.ru

 

Investor Relations

Sergei Levitskiy

Tel: +7 (495) 730 66 00

s.levitskiy@sistema.ru

 

Sistema PJSFC is a publicly traded, diversified Russian holding company in sectors including telecommunications, high technology, financial services, retail, e-commerce, paper and packaging, agriculture, real estate, tourism and medical services. The company was founded in 1993. Revenue in 2021 was RUB 802.4 billion; total assets as of 31 December 2021 amounted to RUB 1.8 trillion. Sistema’s global depositary receipts are listed under the ticker “SSA” on the London Stock Exchange. Sistema’s ordinary shares are listed under the ticker “AFKS” on Moscow Exchange. Website: www.sistema.ru.

 


ISIN:US48122U2042
Category Code:MSCM
TIDM:SSA
LEI Code:213800JSZ2UUK4QQK694
Sequence No.:181751
EQS News ID:1421587
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
30th Sep 201912:40 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
25th Sep 201911:00 amEQSSistema PJSFC: Sistema rating raised to ruA by Expert RA
23rd Sep 20195:30 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
17th Sep 20197:45 amEQSSistema PJSFC: Sistema launches RUB 3.0 billion share repurchase programme
30th Aug 201911:11 amEQSSistema PJSFC: Sistema credit rating raised to BB- by S&P
29th Aug 20198:11 amEQSSistema PJSFC: Sistema announces financial results for the second quarter 2019
12th Aug 20197:45 amEQSSistema PJSFC: Sistema to sell 49% of Leader Invest to Etalon Group
8th Aug 20197:50 amEQSSistema PJSFC: Sistema completes transaction to become shareholder of pharmaceutical businesses Sintez and Biocom
19th Jul 20193:15 pmEQSSistema PJSFC: Sistema closes order book on RUB 10 bn series 001Р-11 exchange-traded bonds
2nd Jul 20195:45 pmEQSSistema PJSFC: Changes in the shareholdings of members of the Board of Directors in Sistema PJSFC
1st Jul 20197:55 amEQSSistema PJSFC: Sistema announces results of AGM and Board of Directors meeting
25th Jun 20192:58 pmEQSSistema PJSFC: Report on Payments to Governments for 2018
17th Jun 20198:45 amEQSSistema PJSFC: Sistema attracts unsecured loan from VTB Bank (PJSC)
7th Jun 201910:38 amEQSSistema PJSFC: Sistema to acquire pharmaceutical companies Sintez and Biocom from Marathon Group
4th Jun 20198:01 amEQSSISTEMA ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER 2019
20th May 20198:00 amEQSSistema announces decisions of the Board of Directors
17th May 20193:00 pmEQSSistema PJSFC: Sistema redeems USD500 million Eurobond
6th May 20195:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
29th Apr 20194:00 pmEQSSistema Annual Report 2018
29th Apr 20197:46 amEQSSistema PJSFC: Sistema increases its stake in Ozon
26th Apr 20198:05 amEQSSistema PJSFC: Correction: Sistema and VTB to create a major pharmaceuticals holding
26th Apr 20198:00 amEQSSistema PJSFC: RDIF, RCIF and Middle Eastern investors to acquire stake in OBL Pharm
3rd Apr 20195:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
3rd Apr 20198:16 amEQSSISTEMA ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2018
1st Apr 20197:48 amEQSSistema announces decisions of the Board of Directors
28th Mar 20193:00 pmEQSSistema closes order book on RUB 10 bn series 001P-10 exchange-traded bonds
5th Mar 20194:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
28th Feb 201912:03 pmEQSSistema PJSFC: Sistema closes order book on RUB 10 bn series 001P-09 exchange-traded bonds
21st Feb 20194:47 pmEQSSistema PJSFC: Acquisition of Sistema shares by Corporation employees
19th Feb 20194:45 pmEQSSistema acquires stake in Ozon from MTS
19th Feb 20194:00 pmEQSSistema becomes largest shareholder of Etalon Group
19th Feb 20194:00 pmRNSSistema Becomes Shareholder of Etalon Group
19th Feb 20197:00 amEQSSistema divests 51% stake in Leader Invest
12th Feb 20194:00 pmEQSSistema divests a stake in MTS Bank
6th Feb 20194:30 pmEQSSistema PJSFC: Sistema successfully completes secondary placement of series 001P-07 bonds
4th Feb 20194:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
28th Dec 20186:55 amEQSSistema and VTB to create a major pharmaceuticals holding
14th Dec 20185:29 pmEQSChanges in the shareholdings of members of the Board of Directors in Sistema PJSFC
29th Nov 20185:20 pmRNSChanges in the shareholdings of members of the BoD
27th Nov 20187:06 amRNSSISTEMA ANNOUNCES FINANCIAL RESULTS FOR 3Q 2018
12th Nov 20184:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
8th Oct 20183:10 pmRNSSistema rating raised to ruA- by Expert RA
3rd Oct 20185:00 pmRNSTransaction under the MTS share buyback programme
11th Sep 201811:30 amRNSAgreement with CapitalBio Technology and RCIF
10th Sep 20187:50 amRNSSistema announces decisions of Board of Directors
4th Sep 20185:00 pmRNSTransaction under the MTS share buyback programme
30th Aug 20188:00 amRNSFINANCIAL RESULTS FOR THE SECOND QUARTER 2018
23rd Aug 201810:40 amRNSSistema improves position in FTSE4Good index
7th Aug 20185:45 pmRNSTransaction under the MTS share buyback programme
30th Jul 201810:30 amRNSSistema secures credit facility from Otkritie Bank

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.